Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001607062-22-000186
Filing Date
2022-03-16
Accepted
2022-03-16 11:07:50
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A sybleu063021form10ka.htm   iXBRL 10-K/A 816963
7 EXHIBIT 31.1 ex31_1.htm EX-31.1 8140
8 EXHIBIT 31.2 ex31_2.htm EX-31.2 10094
9 EXHIBIT 32.1 ex32_1.htm EX-32.1 4778
10 EXHIBIT 32.2 ex32_2.htm EX-32.2 4800
  Complete submission text file 0001607062-22-000186.txt   3213747

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cik0001818674-20210630.xsd EX-101.SCH 25804
3 XBRL CALCULATION FILE cik0001818674-20210630_cal.xml EX-101.CAL 38550
4 XBRL DEFINITION FILE cik0001818674-20210630_def.xml EX-101.DEF 55594
5 XBRL LABEL FILE cik0001818674-20210630_lab.xml EX-101.LAB 168831
6 XBRL PRESENTATION FILE cik0001818674-20210630_pre.xml EX-101.PRE 145029
47 EXTRACTED XBRL INSTANCE DOCUMENT sybleu063021form10ka_htm.xml XML 444661
Mailing Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001
Business Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001 6192279192
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 333-248059 | Film No.: 22743761
SIC: 2834 Pharmaceutical Preparations